Generated by AI
Simulations Plus Inc. is a healthcare technology company that develops modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and life sciences industries. The company’s products help customers support drug discovery, preclinical research, clinical development, regulatory submissions, and commercialization by improving how drug behavior and molecular properties are analyzed. Its software portfolio includes tools used for biosimulation, pharmacokinetic and pharmacodynamic modeling, and prediction of absorption, distribution, metabolism, excretion, and toxicity characteristics. Simulations Plus also provides professional services that complement its software by helping clients apply model-informed approaches across the drug development process. The company serves a global customer base that includes pharmaceutical companies, biotech firms, and research organizations.
Website800 Park Offices Drive
Research Triangle Park, NC, 27709
United States
The latest articles about SLP.
RESEARCH TRIANGLE PARK, N.C., October 06, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC ("Altaris"), an investment firm focused exclusively on the healthcare industry.
Summary of May 6's posts. Generated by AI.
No summary yet.
Summary of Jul 15's posts. Generated by AI.
Investors talking about SLP also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.